Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theresa Bunse

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|July 28, 2016
Concepts in glioma immunotherapyMichael Platten, Lukas Bunse, Wolfgang Wick, et al.
Cancer Cell|October 20, 2023
Tumor-reactive T helper cells in the context of vaccination against gliomaBinghao Zhao, Michael Kilian, Theresa Bunse, et al.
International Journal of Molecular Sciences|December 10, 2021
Genetically Modified Cellular Therapies for Malignant GliomasMichael Kilian, Theresa Bunse, Wolfgang Wick, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 28, 2022
Clinical and Translational Advances in Glioma ImmunotherapyLukas Bunse, Theresa Bunse, Christopher Krämer, et al.
Science Immunology|October 3, 2025
The immunology of brain tumorsLukas Bunse, Theresa Bunse, Michael Kilian, et al.
Current Treatment Options in Neurology|March 30, 2018
Vaccine Strategies in GliomasMichael Platten, Lukas Bunse, Dennis Riehl, et al.
Journal of Neuroimmunology|July 12, 2016
General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammationMelanie Keil, Jana K Sonner, Tobias V Lanz, et al.
Oncoimmunology|August 17, 2017
K27M-mutant histone-3 as a novel target for glioma immunotherapyKatharina Ochs, Martina Ott, Theresa Bunse, et al.
Cancer Research Communications|July 26, 2024
Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain MetastasesJulia Gellert, Dennis A Agardy, Swaminathan Kumar, et al.
Neuro-Oncology|May 24, 2022
Dysfunctional dendritic cells limit antigen-specific T cell response in gliomaMirco Friedrich, Markus Hahn, Julius Michel, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|July 28, 2016
Concepts in glioma immunotherapyMichael Platten, Lukas Bunse, Wolfgang Wick, et al.
Cancer Cell|October 20, 2023
Tumor-reactive T helper cells in the context of vaccination against gliomaBinghao Zhao, Michael Kilian, Theresa Bunse, et al.
International Journal of Molecular Sciences|December 10, 2021
Genetically Modified Cellular Therapies for Malignant GliomasMichael Kilian, Theresa Bunse, Wolfgang Wick, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 28, 2022
Clinical and Translational Advances in Glioma ImmunotherapyLukas Bunse, Theresa Bunse, Christopher Krämer, et al.
Science Immunology|October 3, 2025
The immunology of brain tumorsLukas Bunse, Theresa Bunse, Michael Kilian, et al.
Current Treatment Options in Neurology|March 30, 2018
Vaccine Strategies in GliomasMichael Platten, Lukas Bunse, Dennis Riehl, et al.
Journal of Neuroimmunology|July 12, 2016
General control non-derepressible 2 (GCN2) in T cells controls disease progression of autoimmune neuroinflammationMelanie Keil, Jana K Sonner, Tobias V Lanz, et al.
Oncoimmunology|August 17, 2017
K27M-mutant histone-3 as a novel target for glioma immunotherapyKatharina Ochs, Martina Ott, Theresa Bunse, et al.
Cancer Research Communications|July 26, 2024
Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain MetastasesJulia Gellert, Dennis A Agardy, Swaminathan Kumar, et al.
Neuro-Oncology|May 24, 2022
Dysfunctional dendritic cells limit antigen-specific T cell response in gliomaMirco Friedrich, Markus Hahn, Julius Michel, et al.
Pageof 3